Capabilities by Region: United States

Greenhill has considerable advisory experience in the United States. Our Managing Directors and professionals have advised clients on transactions involving many of the leading companies in the region and have access to a vast network of corporate relationships throughout United States.

Greenhill established its presence in the United States in January 1996 with the opening of our office in New York. Greenhill further expanded its U.S. presence with the opening of Chicago and San Francisco offices in 2008 and the Houston office in 2009.

For more information on Greenhill’s advisory practice in the United States and our capabilities in the region, please contact Chief Executive Officer Scott Bok or President Kevin Costantino in our New York office.

Below we highlight a few of the transactions on which we have advised in this region:

Recent Transactions

04-Dec-23
$530 million
United States flag
Target: 

FW Murphy Production Controls

United States flag
Acquiror: 
Dover Corporation

Advised Genisys Controls LLC on the sale of FW Murphy Production Controls, an instrumentation company that provides advanced monitoring and protection solutions used in sophisticated process applications, to Dover Corporation, a diversified global manufacturer and solutions provider

16-Nov-23
~$400 million
United States flag
Target: 

Sonoma-Cutrer Vineyards (Brown-Forman)

United States flag
Acquiror: 
The Duckhorn Portfolio

Advised Brown-Forman, the largest American-owned spirits and wine company, on its sale of Sonoma-Cutrer Vineyards to The Duckhorn Portfolio

14-Nov-23
Undisclosed
United States flag
Target: 

Minerals and Royalties Interest

United States flag
Acquiror: 
Undisclosed

Advised a company on the sale of its minerals and royalties interests in the Appalachian Basin

04-Oct-23
$610 million
United States flag
Target: 

Lucky Bucks, LLC

flag not available

Advised the Term Loan Ad Hoc Group to Lucky Bucks, one of the largest Class B coin operated amusement machine (“COAM”) route operators in Georgia, on Lucky Bucks’ financial restructuring and chapter 11 process

27-Sep-23
Undisclosed
United States flag
Target: 

Slayback Pharma LLC

United States flag
Acquiror: 
Azurity Pharmaceuticals

Advised Azurity Pharmaceuticals, a pharmaceutical company specializing in the provision of innovative medicines to overlooked patients, on the acquisition of Slayback Pharma LLC ("Slayback"), a company focused on complex generic and specialty pharmaceutical products

Pages

show all